All In Biotech

Drug Trial Radar · NCT07258511

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

A Phase 3 Randomized Study Comparing JNJ-79635322 and an Anti-BCMAxCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy Including a PI, an IMiD, and an Anti CD38 Antibody

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 400 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

400

Planned (sponsor's estimate)

Start

Feb 4, 2026

Primary completion

Dec 12, 2028

Study completion Sep 30, 2031

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Dec 2, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate how well JNJ-79635322 works when compared with an anti-B-cell maturation antigen (BCMA)xCD3 bispecific antibody.

Conditions

  • Multiple Myeloma

Interventions

  • JNJ-79635322Drug

    JNJ-79635322 will be administered as SC injection.

  • TeclistamabDrug

    Teclistamab will be administered as SC injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall ResponseTime frame: Up to 5 years and 7 months
  2. Progression-Free Survival (PFS)Time frame: Up to 5 years and 7 months

Locations

157 sites in 15 countries. Site status is shown where the registry gives one.

  • Mayo Clinic Phoenix

    Phoenix, Arizona · Recruiting

  • UAMS

    Little Rock, Arkansas · Recruiting

  • City of Hope Duarte

    Duarte, California · Recruiting

  • City of Hope Orange County Lennar Foundation Cancer Center

    Irvine, California · Recruiting

  • USC Norris Comprehensive Cancer Center

    Los Angeles, California · Recruiting

  • UCLA Medical Center

    Los Angeles, California · Recruiting

  • University of California San Francisco

    San Francisco, California · Recruiting

  • Colorado Blood Cancer Institute

    Denver, Colorado · Recruiting

  • University of Connecticut Health Center

    Farmington, Connecticut · Recruiting

  • Yale Cancer Center

    New Haven, Connecticut · Recruiting

  • Florida Cancer Specialists & Research Institute

    Fort Myers, Florida · Recruiting

  • Mayo Clinic Jacksonville

    Jacksonville, Florida · Recruiting

  • University of Miami Hospital

    Miami, Florida · Recruiting

  • Moffit Cancer center

    Tampa, Florida · Recruiting

  • Emory University

    Atlanta, Georgia · Recruiting

  • City of Hope Chicago

    Zion, Illinois · Recruiting

  • University of Iowa Hospital and Clinics

    Iowa City, Iowa · Recruiting

  • Mission Cancer Blood

    Waukee, Iowa · Recruiting

  • University of Kansas Cancer Center

    Kansas City, Kansas · Recruiting

  • Norton Cancer Institute

    Louisville, Kentucky · Recruiting

  • University of Maryland School of Medicine

    Baltimore, Maryland · Recruiting

  • Dana Farber Cancer Institute

    Boston, Massachusetts · Recruiting

  • Boston University Medical Center

    Boston, Massachusetts · Recruiting

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts · Recruiting

  • University of Michigan Rogel Cancer Center

    Ann Arbor, Michigan · Recruiting

  • Mayo Clinic Rochester

    Rochester, Minnesota · Recruiting

  • Mount Sinai Brooklyn

    Brooklyn, New York · Recruiting

  • NYU Winthrop

    Mineola, New York · Recruiting

  • Mount Sinai Chelsea

    New York, New York · Recruiting

  • Laura and Isaac Perlmutter Cancer Center NYU ACC

    New York, New York · Recruiting

  • Icahn School of Medicine at Mount Sinai

    New York, New York · Recruiting

  • Memorial Sloan Kettering Cancer Center

    New York, New York · Recruiting

  • University of North Carolina

    Chapel Hill, North Carolina · Recruiting

  • Durham VAMC

    Durham, North Carolina · Recruiting

  • Cleveland Clinic

    Cleveland, Ohio · Recruiting

  • Oregon Health And Science University

    Portland, Oregon · Recruiting

  • Thomas Jefferson University Hospital

    Philadelphia, Pennsylvania · Recruiting

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania · Recruiting

  • SCRI Oncology Partners

    Nashville, Tennessee · Recruiting

  • Vanderbilt University Medical Center

    Nashville, Tennessee · Recruiting

Showing 40 of 157 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.